Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-49 - Serial Changes in Whole-Genome Cell-Free DNA (cfDNA) to Identify Disease Progression Prior to Imaging in Advanced NSCLC
09:45 - 09:45 | Presenter: Young Kwang Chae | Author(s): Andrew A. Davis, Wade T Iams, David Chan, Michael S Oh, Robert W Lentz, Neil Peterman, Alex Robertson, Abhik Shah, Rohith Srivas, Nicole Lambert, Timothy Wilson, Ayse Tezcan, John C. Spinosa, Haluk Tezcan, Nisha Anjali Mohindra, Victoria Meucci Villaflor
- Abstract
Loading... -
+
P1.01-67 - Ph I/II Carboplatin, Nab-Paclitaxel and Pembrolizumab for Advanced NSCLC (HCRN LUN13-175): Outcomes by Nab-Paclitaxel Dose
09:45 - 09:45 | Presenter: Ryan D Gentzler | Author(s): Nisha Anjali Mohindra, Shadia I Jalal, Karen L Reckamp, Richard D Hall, Nasser Hanna, Young Kwang Chae, Victoria Meucci Villaflor, Marianna Koczywas, Irene B Helenowski, Alfred W Rademaker, Jyoti D Patel
- Abstract
Loading...
-
+
P1.03 - Biology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P1.03-38 - EGFR Mutation Status as a Prognostic Marker in Stage 1 Lung Adenocarcinoma After Definitive Surgical Resection
09:45 - 09:45 | Presenter: Carlos Galvez | Author(s): Saya Jacob, Jeffrey Zhao, Kyle Tegtmeyer, Brian Finkelman, Young Kwang Chae, Nisha Anjali Mohindra, Borko Jovanovic, Amir Behdad, Victoria Meucci Villaflor
- Abstract
Loading...
-
+
P1.17 - Treatment of Early Stage/Localized Disease
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
-
+
P1.17-40 - Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment
09:45 - 09:45 | Presenter: Nicholas I. Simon | Author(s): Young Kwang Chae, Nisha Anjali Mohindra, Victoria Meucci Villaflor
- Abstract
Loading...
